Key facts
- This page summarizes Darin J. Weber's Form 4 filing for PROKIDNEY CORP. (PROK).
- 3 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 29 Aug 2023, 21:25.
Darin J. Weber - 25 Aug 2023 Form 4 Insider Report for PROKIDNEY CORP. (PROK)
- Reporting relationship
- SVP of Regulatory Development
- Issuer ticker
- PROK
- Reported as of
- 25 Aug 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 29 Aug 2023, 21:25:00 UTC
- Prior SEC filing
- 18 Jan 2023
- Next SEC filing
- 06 Feb 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Todd Girolamo, as Attorney-in- Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
Darin J. Weber filed Form 4 for PROKIDNEY CORP. (PROK) on 29 Aug 2023.
Change
- Previous filing in this sequence was filed on 18 Jan 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PROK
transaction
Class A Ordinary Shares
Conversion of derivative security
- Transaction value
- $0
- Shares
- +137,000
- Change %
- Price
- $0.000000
- Shares after
- 137,000
- Date
- 25 Aug 2023
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
PROK
transaction
Derivative
Class B Ordinary Shares
Conversion of derivative security
- Transaction value
- $0
- Shares
- -137,000
- Change %
- -20%
- Price
- $0.000000
- Shares after
- 539,356
- Date
- 25 Aug 2023
- Ownership
- Direct
- Underlying class
- Class A Ordinary Shares
- Underlying amount
- 137,000
- Exercise price
- $0.000000
- Footnotes
- F1, F2
PROK
transaction
Derivative
Common Units in ProKidney LP
Conversion of derivative security
- Transaction value
- $0
- Shares
- -137,000
- Change %
- -20%
- Price
- $0.000000
- Shares after
- 539,356
- Date
- 25 Aug 2023
- Ownership
- Direct
- Underlying class
- Class A Ordinary Shares
- Underlying amount
- 137,000
- Exercise price
- $0.000000
- Footnotes
- F1, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
The Class B Ordinary Shares and the Common Units in ProKidney LP (a "Common Unit") are paired securities. At the election of the reporting person and subject to the limitations set forth in the Exchange Agreement and and the Second Amended and Restated Company Partnership Agreement, each Class B Ordinary Share, together with a paired Common Unit, may be exchanged for Class A Ordinary Shares on a one-for-one basis. On August 25, 2023, the reporting person provided ProKidney Corp. (the "Issuer") with notice of exchange, which exchange will be settled 60 days following the closing of the exchange period under the terms of the Exchange Agreement.
Footnote F2
The Class B Ordinary Shares were received pursuant to the terms of the Business Combination Agreement by and between the Issuer (formerly known as Social Capital Suvretta Holdings Corp. III) and ProKidney LP, dated as of January 18, 2022 (the "Business Combination Agreement"), in exchange for historical interests held by the reporting person in ProKidney LP. The Class B Ordinary Shares do not expire.
Footnote F3
The Common Units were received pursuant to the terms of the Business Combination Agreement in exchange for historical interests held by the reporting person in ProKidney LP. The Common Units do not expire.